Company
EUPRAXIA PHARMACEUTICALS INC. (EPRX)
Standardized SEC financial data for EUPRAXIA PHARMACEUTICALS INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001581178 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-48.0%
Free cash flow
-$28.6M
Current ratio
15.12×
EPS (diluted)
$-1.03
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 |
| R&D expense | $13.6M | $20.4M | $16.1M | $21.3M |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $12.5M | $18.3M | $19.3M | $33.1M | $80.6M |
| Total current assets | — | $18.6M |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$14.4M | -$20.7M | -$30.0M | -$28.6M |
| Investing cash flow | $9.8M | -$73K | -$75K | -$589K |
Get EPRX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/EPRX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/EPRX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"